These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 19057024)

  • 1. Endothelialization of sirolimus-eluting stents with slow and extended drug release in the porcine overstretch model.
    Frey D; Billinger M; Meier P; Beslac O; Grossenbacher R; Hänni B; Hess OM
    J Invasive Cardiol; 2008 Dec; 20(12):631-4. PubMed ID: 19057024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.
    Nakazawa G; Finn AV; John MC; Kolodgie FD; Virmani R
    Am J Cardiol; 2007 Oct; 100(8B):36M-44M. PubMed ID: 17950831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.
    Tada N; Virmani R; Grant G; Bartlett L; Black A; Clavijo C; Christians U; Betts R; Savage D; Su SH; Shulze J; Kar S
    Circ Cardiovasc Interv; 2010 Apr; 3(2):174-83. PubMed ID: 20407114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents.
    van Beusekom HM; Sorop O; van den Heuvel M; Onuma Y; Duncker DJ; Danser AH; van der Giessen WJ
    EuroIntervention; 2010 May; 6(1):117-25. PubMed ID: 20542807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
    Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
    J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell recovery between comparator polymer-based drug-eluting stents.
    Joner M; Nakazawa G; Finn AV; Quee SC; Coleman L; Acampado E; Wilson PS; Skorija K; Cheng Q; Xu X; Gold HK; Kolodgie FD; Virmani R
    J Am Coll Cardiol; 2008 Jul; 52(5):333-42. PubMed ID: 18652940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
    van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction.
    Obata JE; Kitta Y; Takano H; Kodama Y; Nakamura T; Mende A; Kawabata K; Saitoh Y; Fujioka D; Kobayashi T; Yano T; Kugiyama K
    J Am Coll Cardiol; 2007 Oct; 50(14):1305-9. PubMed ID: 17903627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
    Joner M; Finn AV; Farb A; Mont EK; Kolodgie FD; Ladich E; Kutys R; Skorija K; Gold HK; Virmani R
    J Am Coll Cardiol; 2006 Jul; 48(1):193-202. PubMed ID: 16814667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.
    Wessely R; Hausleiter J; Michaelis C; Jaschke B; Vogeser M; Milz S; Behnisch B; Schratzenstaller T; Renke-Gluszko M; Stöver M; Wintermantel E; Kastrati A; Schömig A
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):748-53. PubMed ID: 15681298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization.
    Nakazawa G; Granada JF; Alviar CL; Tellez A; Kaluza GL; Guilhermier MY; Parker S; Rowland SM; Kolodgie FD; Leon MB; Virmani R
    JACC Cardiovasc Interv; 2010 Jan; 3(1):68-75. PubMed ID: 20129572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction.
    Kim JW; Seo HS; Park JH; Na JO; Choi CU; Lim HE; Kim EJ; Rha SW; Park CG; Oh DJ
    J Am Coll Cardiol; 2009 May; 53(18):1653-9. PubMed ID: 19406340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries.
    Sperling C; Waliszewski MW; Kherad B; Krackhardt F
    Ther Adv Cardiovasc Dis; 2019; 13():1753944719826335. PubMed ID: 30803407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor protein levels and gene expression in peripheral monocytes after stenting: a randomized comparative study of sirolimus: eluting and bare metal stents.
    Kochiadakis GE; Marketou ME; Panutsopulos D; Arfanakis DA; Skalidis EI; Igoumenidis NE; Hamilos MI; Sourvinos G; Chlouverakis G; Spandidos D; Vardas PE
    Eur Heart J; 2008 Mar; 29(6):733-40. PubMed ID: 18305085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
    Jabara R; Chronos N; Robinson K
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelialization of nonapposed stent struts located over the origin of a side branch: results with different carbofilm-coated stents.
    Perez De Prado A; Perez Martinez C; Cuellas Ramon C; Gonzalo Orden JM; Altonaga JR; Iglesias MJ; Regueiro Purriños M; Orden MA; Marin JF; Fernandez-Vazquez F
    J Interv Cardiol; 2009 Jun; 22(3):222-7. PubMed ID: 19490356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.